Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methods to increase PpIX formation in the skin of healthy volunteers
2014-001440-38Phase 2Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Apr 2014
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methyl aminolevulinate and 5-aminolevulinic acid (4 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: PpIX formation over 24 hours. Started Apr 2014; status: completed.
02
Drugs
methyl aminolevulinate5-aminolevulinic acid
Beyond the preview
Go deeper on 2014-001440-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001440-38.